Cutaneous Melanoma: IMA203 Treatment Study

We are comparing a new treatment called IMA203 with the best available options for patients with advanced skin cancer. This study aims to see if IMA203 is more effective and safe for those who have already been treated.

1-2 years 11-15 visits Confirmation phase (III)No Placebo Cost Reimbursement Partially Remote Investigational Medicines Oral InjectionOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Carboplatin

Carboplatin is a chemotherapy medicine used to treat various types of cancer.

Dacarbazine

Dacarbazine is a chemotherapy medicine used to treat certain cancers, such as melanoma and Hodgkin lymphoma.

Paclitaxel

Paclitaxel is a chemotherapy medicine used to treat various types of cancer.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Carboplatin

Carboplatin is a chemotherapy substance used to treat various cancers by damaging cancer cells and slowing tumor growth.

Dacarbazine

Dacarbazine is a chemotherapy substance used to treat certain cancers, including melanoma and Hodgkin lymphoma.

Dacarbazine Citrate

Dacarbazine citrate is an anticancer substance used to treat certain cancers, including melanoma and Hodgkin lymphoma.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Ima203

Opdualag

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abutrax

Apexelsin

Axitaxel

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Universitaetsklinikum Bonn AöR

Medizinische Klinik und Poliklinik III

Bonn, Germany

Technische Universitaet Dresden

Early Clinical Trial Unit (NCT/UCC ECTU)

Dresden, Germany

Universitaetsklinikum Erlangen AöR

Department of Dermatology

Erlangen, Germany

Sponsor: Immatics US Inc.

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.